Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋

Vascular cardiologist|Aorta|Platelet|PE. Opinion w/ interest in cardiac/vascular care🚫employer. @EdinburghUni @UR_Med @UpstateNews @WCM_MedChiefs #MartialArts

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

1/2 Terrific collaboration with Dr. Vitaliy Rayz from @LifeAtPurdue. Computational modeling of platelet activation in CAS and FMD. First author @SumanGuntupalli from @CCLRI Image and revisions courtesy of PhD student @edelyn_park. Next generation stroke risk stratification.

[Cardiovascular Business @CardioBusiness]

New data suggest clinicians have been making a mistake when diagnosing PAD #cardiology @JACCjournals @ACCinTouch https://t.co/VjvCgAW39z

[Cardiovascular Business @CardioBusiness]

“It’s indisputable that this particular genotype influences the effectiveness of clopidogrel," said lead author Lari Cavallari, PharmD, University of Florida.

#DAPT #Cardiology #interventionalcardiology https://t.co/yfGpqdMmQg

[Jennifer Kwan MD PhD @jennkwanMDPhD]

🧪58% early career phys-sci considering leaving research
📉72% cite $ instability as major driver
🌎43.9% considering leaving US for research abroad
🔥Burnout,⬇️research⏲️➡️attrition. Proud to partner w/@theNAMedicine for new phy-sci initiative https://t.co/xf5LKfctkg @AbushoukMD

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

https://t.co/u7nhcPNHL6

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

2/2 Nice h/t to an Irish-born, Scottish trained physician who pioneered transvenous heart biopsy during his time at Stanford.🇮🇪🏴󠁧󠁢󠁳󠁣󠁴󠁿 https://t.co/Ror8qRiyyu

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

1/2 One of the most innovative presentations I’ve seen in a while today by @KiranKhush1 from @Stanford. Donor derived cell free DNA circulating in the blood as an alternative to endomyocardial biopsy to evaluate cardiac transplant rejection. https://t.co/RsMyMx1c6F #MedEd

[EHJ Editor-in-Chief @ehj_ed]

Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial . Read more in the @EHJ at https://t.co/XiFw6d2ROp #Digoxin #HeartFailure #Cardiology #DECISIONTrial @ESCardio @ESC_Journals

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

A little history on megakaryocytes by @BRamkhelawonLab before the 🎤 drop: MKs can be reprogrammed in AAA. Different kind of platelet. Also the 🫁 (where MKs also are) talks to the aorta. #VascularDoscovery2026

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

@JuyeunLee31 @Nature Congratulations !!

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

2/2 ‼️ New technology📸. Ahead of print: https://t.co/5agoBlQRF5
#MedEd #Vascular #FMD @SVM_tweets @ccfvascmed @FmdSupport @FMDartery @AnuAggarwal86

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

1/2 Terrific collaboration with Dr. Vitaliy Rayz from @LifeAtPurdue. Computational modeling of platelet activation in CAS and FMD. First author @SumanGuntupalli from @CCLRI Image and revisions courtesy of PhD student @edelyn_park. Next generation stroke risk stratification.

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

Wonderful vascular medicine capstone grand rounds by @Dr_AravindDB today. Thrombosis vs. bleeding risk w/ anrithrombotic therapy after Watchman device placement. Need to consider bleeding 🩸 risk comorbid conditions (📉 platelets) vs thrombosis comorbid conditions (PAD) #MedEd

[Harrison Ford @HarrisonFordLA]

May the fourth be with you

[EHJ Editor-in-Chief @ehj_ed]

Multimodality non-invasive cardiovascular screening reduces 5-year all-cause mortality in both sexes!
https://t.co/vg7F2fJLke
#multimodality #screening #cardiotwitter @ESC_Journals @escardio

[ATVB: An AHA Journal @atvbahajournals]

Anti-inflammatory therapy targeting interleukin 6 receptor attenuate platelet activation in patients with myocardial infarction @KasparBroch @TuvaBDahl @BenteHalvo84025 @Halvorsen Lab_RIIM
https://t.co/WeAH5ftaQb

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

6/6

FAILURE WON’T KEEP US IN OUR LANE. 📣

IT IS OUR METAPHORICAL HIGHWAY. 🛣️

Join me. 🧬🧫🔬

#MedEd #Resilience #Research

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

1/6🧵
Failure isn’t a detour in science — it is THE path.

And talking about it openly makes us stronger and helps our students. 👩🏼‍🎓👨🏼‍🎓

I didn’t get funded in a truly weird NIH category this cycle. Many scientists feel that the changing rules have become harder to interpret.

[Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 @2Scottish]

5/6

To all of my scientific wounded warriors this weekend 🥊:

Your grit is your superpower. The fight in the dog will always outlast the dog in the fight.

Keep showing up.
Keep collaborating.
Keep choosing kindness.
Keep perspective.